Aktie A3CMW8 VECTIVBIO HOLDING AG
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen VectivBio Holding AG

Aktien

A3CMW8

CH1109007893

VECT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
VectivBio : Articles of Association of VectivBio Holding AG, as amended - Form 6-K
VectivBio Holding AG(NasdaqGS:VECT) dropped from NASDAQ Composite Index
ALENTIS THERAPEUTICS APPOINTS LUCA SANTARELLI AS CHAIRPERSON
Sector Update: Health Care Stocks Advancing Late Thursday
Sector Update: Health Care Stocks Higher Thursday Afternoon
Ironwood Pharmaceuticals, VectivBio Say Tender Offer for VectivBio Shares Completed
Ironwood Pharmaceuticals, Inc. completed the acquisition of VectivBio Holding AG from Versant Venture Capital V, L.P., managed by Versant Venture Management, LLC, Forbion Growth Opportunities Fund II, managed by Forbion Capital Partners B.V., OrbiMed Advisors LLC and others.
VectivBio Says Takeover by Ironwood Pharmaceuticals Approved at Extraordinary Shareholder Meeting
VectivBio Extraordinary General Meeting of Shareholders Approved All Proposals
Ironwood Pharmaceuticals Tender Offer for VectivBio Clears Antitrust Waiting Period
VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT
VectivBio : Invitation to the Extraordinary General Meeting - Form 6-K
VectivBio Holding Ag Approves Amendments to the Articles of Association
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECT, RTL, APGN
Moore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law Firm
VECTIVBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of VectivBio Holding AG - VECT
VectivBio : IRONWOOD PHARMACEUTICALS, INC - Form 6-K
Health Care Up Slightly as Pfizer Rallies on Weight-Drug Hopes -- Health Care Roundup
Ironwood Pharmaceuticals to Buy VectivBio for $1 Billion, Enhancing Gastrointestinal Portfolio
Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CMW8 Aktie
  4. Nachrichten VectivBio Holding AG
  5. Andere Sprachen